Glucagon‐like peptide agonists: A prospective review
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as promising therapeutic options for addressing Type‐2 diabetes, obesity, and related conditions. Among these, semaglutide, tirzepatide, liraglutide etc., all notable GLP‐1RA, have gained attention owing to their f...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2024-01-01
|
| Collection: | Endocrinology, Diabetes & Metabolism |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/edm2.462 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|